A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
Clinical trial NCT05317494 · RECRUITING
Trial details
- NCT number
- NCT05317494
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-26
- Primary completion
- 2026-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.